Neon Therapeutics’ Personalized Vaccine Approach Progresses With Combination Immunotherapy Trial – GenomeWeb
|
Neon Therapeutics' Personalized Vaccine Approach Progresses With Combination Immunotherapy Trial
GenomeWeb NEW YORK (GenomeWeb) – Cambridge, Massachusetts-based Neon Therapeutics is continuing to make progress in its quest to use predicted neoantigen profiles in tumor samples for developing cancer vaccines and adoptive T cell therapies that can be … |
